Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chongzhi Gan"'
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 20, Iss 1, Pp 1-7 (2022)
Abstract Objectives Surgical lung resection involves a critical task of stapled ligation and transection of major vascular structures and tissue, which may lead to bleeding and complications. A newer powered stapling system with Gripping Surface Tech
Externí odkaz:
https://doaj.org/article/3de1a4cf9f204c7ab468f7140a518e73
Publikováno v:
Cancer Cell International, Vol 18, Iss 1, Pp 1-16 (2018)
Abstract Background Lung cancer is a malignant tumor with the highest incidence and mortality around the world. Recent advances in RNA sequencing technology have enabled insights into long non-coding RNAs (lncRNAs), a previously largely overlooked sp
Externí odkaz:
https://doaj.org/article/88a290e714474310ae0f5b7734fb0567
Publikováno v:
Chinese Journal of Lung Cancer, Vol 19, Iss 9, Pp 571-576 (2016)
Background and objective The inhibitory ability of miR-424 on the proliferation of renal carcinoma cell and the migration and invasion of cancer cells has been widely explored and demonstrated. However, the effects of miR-424 on non-small cell lung c
Externí odkaz:
https://doaj.org/article/08d79182ccfe4404bb4951a029b97032
Objectives Surgical lung resection involves a critical task of stapled ligation and transection of major vascular structures and tissue, which may lead to bleeding and complications. A newer powered stapling system with Gripping Surface Technology (G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4ac43ff77aefd51956941d01aaac63c
https://doi.org/10.21203/rs.3.rs-1614893/v1
https://doi.org/10.21203/rs.3.rs-1614893/v1
Publikováno v:
IUBMB Life. 69:841-849
Lung cancer is a leading cause of cancer-related mortality, and non-small-cell lung carcinoma is responsible for almost 80% of lung cancer-related deaths. In recent years, lung cancer has shown increasing incidence but poor prognosis, and many studie
Publikováno v:
Molecular Medicine Reports
Celecoxib is an inhibitor of cyclooxygenase-2, a gene that is often aberrantly expressed in the lung squamous cell carcinoma (LSQCC). The present study aims to provide novel insight into chemoprevention by celecoxib treatment. The human LSQCC cell li
Autor:
Chongzhi, Gan, Wei, Cong
Publikováno v:
Zhongguo fei ai za zhi = Chinese journal of lung cancer. 5(3)
To evaluate the efficacy of pulmonary artery infusion (PAI) via post-catheter connecting system in patients with lung cancer after lobectomy.Ninety patients were randomized into two groups after lobectomy and each group had 45 patients. The PAI group